Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Explore the breakthrough in vagus nerve stimulation enhancing treatment for chronic illnesses by syncing with natural rhythms ...

In today’s fast-paced world, maintaining optimal nerve health is paramount for overall well-being. Nerve-related issues can significantly impact daily life, leading to discomfort, difficulty in ...